Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Harnessing the PD-1 Pathway in Myelodysplastic Syndrome.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Harnessing the PD-1 Pathway in Myelodysplastic Syndrome.
Harnessing the PD-1 Pathway in Myelodysplastic Syndrome. Am J Ther. 2018 Nov/Dec; 25(6):e711-e712.
View in:
PubMed
subject areas
Aged
Aged
Anemia, Refractory, with Excess of Blasts
Anemia, Refractory, with Excess of Blasts
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
Biopsy
Biopsy
Bone Marrow
Bone Marrow
Female
Female
Hemoglobins
Hemoglobins
Humans
Humans
Leukocyte Count
Leukocyte Count
Platelet Count
Platelet Count
Programmed Cell Death 1 Receptor
Programmed Cell Death 1 Receptor
Treatment Outcome
Treatment Outcome
authors with profiles
Raid Aljumaily
Sami Ibrahimi